Webinars
Videos from wcgclinical's Wistia project
-
1:05:26Watch VideoAddressing Acceptable Recruitment Methods
-
1:03:56Watch VideoGene Therapy for Rare and Ultra-rare Diseases
-
56:41Watch VideoRare & Orphan Disease Endpoints: Challenges & Examples from Neurodevelopment
-
52:22Watch VideoRecruiting Patients & Time Management: Top Tips for Dealing with the Most Critical Resource in Research
-
1:00:47Watch VideoStrategies that Inform Investigator Selection and Enhance Enrollment
-
57:35Watch VideoUnderstanding the Challenges of Managing Combination Product Safety Reporting
-
58:12Watch VideoBigger, Better, Faster and More: How Institutions Can Increase Funding, Improve Research and Speed Enrollment
-
58:17Watch VideoDo the Right Thing: Unique Ethical Issues in Oncology Research
-
58:43Watch VideoPlacebo Response in Clinical Trials: Approaches to Mitigation
-
1:01:04Watch VideoOperationalizing the NIH Single IRB Mandate
-
54:41Watch VideoOptimizing Global Safety Reporting in Clinical Trials
-
1:00:21Watch VideoSolving The Problem of Clinical Research Enrollment
-
1:01:49Watch VideoSpeed, Efficiency and Accuracy in Site Contracts and Payments
Learn how sponsors and CROs can optimize site contracting and payments management to expedite the process of contract negotiation, reducing both the cycle time and burden on the legal infrastructure.
-
56:00Watch VideoIs Facebook Hurting Your Study? Ethical and Study Integrity Concerns When Participants Use Social Media
-
1:00:34Watch VideoFifty Years of Change: Henry K. Beecher and Protecting Human Subjects
-
56:38Watch VideoHarnessing the Power of Data to Optimize Site Selection for Clinical Trials
-
58:07Watch VideoA Discussion of the Revised Common Rule - Jan 2017
-
56:02Watch VideoEarly Access to Investigational Drugs: Lessons Learned from Ebola
Learn about the regulatory framework that governs the use of investigational drugs outside clinical trials (formerly called “compassionate use”), and the ethical challenges surrounding it.
-
56:14Watch VideoClinical Data Disclosure: The Complicated Efforts to Make Research Transparent
Learn status of the requirements and recommendations for data-sharing from EMEA, FDA and PhRMA, and how to determine the steps to navigate the complicated field of data transparency compliance.
-
53:26Watch VideoIRBNet and VA Medical Centers: A Powerful Partnership Made Even Easier
-
Loading More...
